HELP     Sign In
Search

Relevance to Autism

Defects in this gene are associated with Pitt-Hopkins syndrome (PTHS) [MIM:610954]. Patients with Pitt-Hopkins syndrome frequently exhibit stereotypic hand and head movements (summarized in Peippo and Ignatius, 2012). More recently, evaluation of 10 Pitt-Hopkins syndrome patients with psychiatric examinations and neuropsychological measurements using a comprehensive assessment battery, including the Autism Diagnostic Interview-Revised (ADI-R), demonstrated that all participants displayed profound intellectual disability, severe impairments in social interactions, severe impairments in communication and language, and highly frequent stereotyped behavior, indicating that in classic Pitt-Hopkins syndrome the behavioral phenotype showed similarities to behaviors seen in ASD (Van Balkom et al., 2012). An intronic marker in TCF4 has demonstrated genome-wide association with schizophrenia in case-control meta-analyzes (PMIDs 19571808, 21791550). Two de novo loss-of-function variants in TCF4 have been identified in ASD probands from the Autism Sequencing Consortium (De Rubeis et al., 2014) and from a cohort of Chinese ASD probands (Guo et al., 2017). Maternally-inherited damaging missense variants in TCF4 were identified in two ASD probands from the Autism Clinical and Genetic Resources in China (ACGC) cohort in Wang et al., 2016. A second de novo protein-truncating variant in TCF4 in an ASD proband from the Autism Sequencing Consortium was reported in Satterstrom et al., 2020; subsequent TADA analysis of de novo variants from the Simons Simplex Collection and the Autism Sequencing Consortium and protein-truncating variants from iPSYCH in this report identified TCF4 as a candidate gene with a false discovery rate (FDR) between 0.01 and 0.05 (0.01 < FDR 0.05). Two additional de novo loss-of-function variants and three potentially damaging de novo missense variants in the TCF4 gene were reported in ASD probands from the MSSNG cohort and the SPARK cohort in Zhou et al., 2022; a two-stage analysis of rare de novo and inherited coding variants in 42,607 ASD cases, including 35,130 new cases from the SPARK cohort, in this report identified TCF4 as a gene reaching study-wide significance based on 5,754 constraint genes (P < 8.69E-06).

Molecular Function

This gene encodes transcription factor 4, a basic helix-loop-helix transcription factor that binds to the immunoglobulin enchancer Mu-E5/KE5-motif and is involved in the initiation of neuronal differentiation. Defects in this gene are associated with Pitt-Hopkins syndrome (PTHS) [MIM:610954], a syndrome characterized by mental retardation, wide mouth and distinctive facial features, and intermittent hyperventilation followed by apnea.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Development, cognition, and behaviour in Pitt-Hopkins syndrome.
Pitt-Hopkins syndrome
ASD
Positive Association
Irritability
Positive Association
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.
SCZ
Positive Association
Common variants at VRK2 and TCF4 conferring risk of schizophrenia.
SCZ
Positive Association
Common variants conferring risk of schizophrenia.
SCZ
Support
Large-scale discovery of novel genetic causes of developmental disorders.
DD
Microcephaly
Support
Functional consequences of TCF4 missense substitutions associated with Pitt-Hopkins syndrome, mild intellectual disability, and schizophrenia
Pitt-Hopkins syndrome, ID, schizophrenia
Support
Diagnostic Yields of Trio-WES Accompanied by CNVseq for Rare Neurodevelopmental Disorders.
Pitt-Hopkins syndrome
Support
The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies.
DD, hypotonia
Support
Integrating de novo and inherited variants in 42
ASD
Support
Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries.
DD
Support
Whole genome sequencing of 45 Japanese patients with intellectual disability
DD, ID
Support
Exome Pool-Seq in neurodevelopmental disorders.
DD
Hypotonia
Support
Pitt-Hopkins syndrome
Support
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Support
Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder
ASD
Support
Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.
ASD
Support
De novo genic mutations among a Chinese autism spectrum disorder cohort.
ASD
Support
Psychiatric risk gene transcription factor 4 preferentially regulates cortical interneuron neurogenesis during early brain development
Support
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.
ASD
Support
Daughterless, the Drosophila orthologue of TCF4, is required for associative learning and maintenance of the synaptic proteome
Support
Targeted sequencing and functional analysis reveal brain-size-related genes and their networks in autism spectrum disorders.
ASD
Support
Pitt-Hopkins syndrome
Support
De novo mutations in moderate or severe intellectual disability.
ID
Absent speech, hypotonia
Support
A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies
DD, ID
ASD, epilepsy/seizures
Support
Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes.
ASD
Support
Knockdown of the schizophrenia susceptibility gene TCF4 alters gene expression and proliferation of progenitor cells from the developing human neoc...
Support
The recurrent TCF4 missense variant p.(Arg389Cys) causes a neurodevelopmental disorder overlapping with but not typical for Pitt-Hopkins syndrome
DD, ID
Epilepsy/seizures
Support
TCF4 deletions in Pitt-Hopkins Syndrome.
Pitt-Hopkins syndrome
Support
Tcf4 is required for correct brain development during embryogenesis
Support
Using medical exome sequencing to identify the causes of neurodevelopmental disorders: experience of two clinical units and 216 patients.
ID
Support
ASD
DD, ID, epilepsy/seizures
Support
Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.
ID
Support
Adult brain neurons require continual expression of the schizophrenia-risk gene Tcf4 for structural and functional integrity
Schizophrenia
Support
Pitt-Hopkins Syndrome: A Unique Case Study.
Pitt-Hopkins syndrome
ASD, ADHD
Support
DD
Stereotypy
Support
Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability
ID
Support
Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content
Pitt-Hopkins syndrome
Support
Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome.
ID
Support
The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing
ID
Support
Genomic diagnosis for children with intellectual disability and/or developmental delay.
ID
Support
Somatic mosaicism detected by exon-targeted, high-resolution aCGH in 10,362 consecutive cases.
ADHD
Support
Comprehensive genetic analysis confers high diagnostic yield in 16 Japanese patients with corpus callosum anomalies
Corpus callosum anomalies
DD, epilepsy/seizures
Support
Tcf4 regulates dendritic spine density and morphology in the adult brain.
Support
Epilepsy/seizures
DD
Support
Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability.
ID
Support
Trio-based exome sequencing reveals a high rate of the de novo variants in intellectual disability
ID
Support
Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome).
Pitt-Hopkins syndrome
Support
Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism
ASD
Support
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
DD
Support
ADHD, ADD, SCZ, DD, ID
Support
Parent-child exome sequencing identifies a de novo truncating mutation in TCF4 in non-syndromic intellectual disability.
ID
Support
Confirming the contribution and genetic spectrum of de novo mutation in infantile spasms: Evidence from a Chinese cohort
Epilepsy/seizures
ASD, DD
Support
Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis.
ID
Stereotypic behavior
Support
ASD
Support
Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
DD
Microcephaly, absent speech
Support
Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genes
ASD
Support
Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic en...
Pitt-Hopkins syndrome
Support
Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
ASD
Support
Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins ...
Support
Depressive disorder, ID
Stereotypy
Support
Pitt-Hopkins Syndrome.
Pitt-Hopkins syndrome
Support
Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing
DD
Support
The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectu...
Support
DD, epilepsy/seizures
Recent Recommendation
A common molecular signature in ASD gene expression: following Root 66 to autism.
Recent Recommendation
Systems genetics identifies a convergent gene network for cognition and neurodevelopmental disease.
Recent Recommendation
Low load for disruptive mutations in autism genes and their biased transmission.
ASD
Recent Recommendation
Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a rol...
Recent Recommendation
The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons...
Recent Recommendation
Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1.
Recent Recommendation
De Novo Synonymous Mutations in Regulatory Elements Contribute to the Genetic Etiology of Autism and Schizophrenia.

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN592R001 
 translocation 
  
  
 De novo 
  
 Simplex 
 GEN592R002 
 translocation 
  
  
 De novo 
  
 Multiplex (monozygotic twins) 
 GEN592R003 
 stop_gained 
 c.469C>T 
 p.Arg157Ter 
 De novo 
  
  
 GEN592R004 
 copy_number_loss 
  
  
 Unknown 
  
 Unknown 
 GEN592R005 
 stop_gained 
 c.1180C>T 
 p.Gln394Ter 
 De novo 
  
 Simplex 
 GEN592R006 
 splice_site_variant 
 c.1171G>A 
 p.Glu391Lys 
 De novo 
  
 Simplex 
 GEN592R007 
 frameshift_variant 
 c.209_212del 
 p.Asn70MetfsTer10 
 De novo 
  
 Simplex 
 GEN592R008 
 stop_gained 
 c.520C>T 
 p.Arg174Ter 
 De novo 
  
 Simplex 
 GEN592R009 
 splice_site_variant 
 c.1487-5G>A 
 p.Arg495_Gly496insAla? 
 Unknown 
 Not maternal 
 Simplex 
 GEN592R010 
 frameshift_variant 
 2240+G(delC) 
 747-! 
 De novo 
  
 Simplex 
 GEN592R011 
 synonymous_variant 
 c.990G>A 
 p.Ser330= 
 De novo 
  
 Simplex 
 GEN592R012 
 missense_variant 
 c.1739G>A 
 p.Arg580Gln 
 Unknown 
  
 Unknown 
 GEN592R013 
 translocation 
  
  
 Familial 
  
 Multi-generational 
 GEN592R014 
 stop_gained 
 c.826C>T 
 p.Arg276Ter 
 De novo 
  
  
 GEN592R015 
 missense_variant 
 c.964G>A 
 p.Gly322Ser 
 Familial 
 Maternal 
  
 GEN592R016 
 missense_variant 
 c.836C>T 
 p.Pro279Leu 
 Familial 
 Maternal 
  
 GEN592R017 
 translocation 
  
  
 De novo 
  
  
 GEN592R018 
 frameshift_variant 
 c.119_127delinsCAAAG 
 p.Phe40SerfsTer7 
 De novo 
  
  
 GEN592R019 
 splice_site_variant 
 c.1489+1G>T 
 p.? 
 De novo 
  
  
 GEN592R020 
 stop_gained 
 c.158C>G 
 p.Ser53Ter 
 De novo 
  
  
 GEN592R021 
 stop_gained 
 c.1726C>T 
 p.Arg576Ter 
 De novo 
  
  
 GEN592R022 
 stop_gained 
 c.1153C>T 
 p.Arg385Ter 
 De novo 
  
 Simplex 
 GEN592R023 
 frameshift_variant 
 c.672delinsGG 
 p.Ser224ArgfsTer33 
 De novo 
  
  
 GEN592R024 
 missense_variant 
 c.850C>T 
 p.His284Tyr 
 Unknown 
  
  
 GEN592R025 
 missense_variant 
 c.2039G>A 
 p.Arg680His 
 De novo 
  
  
 GEN592R026 
 frameshift_variant 
 c.2263_2264del 
 p.Ser755LeufsTer57 
 De novo 
  
  
 GEN592R027 
 stop_gained 
 c.673C>T 
 p.Gln225Ter 
 De novo 
  
 Simplex 
 GEN592R028 
 splice_region_variant 
 c.1296G>A 
 p.Ser432= 
 De novo 
  
  
 GEN592R029 
 stop_gained 
 c.873C>A 
 p.Tyr291Ter 
 De novo 
  
 Multiplex 
 GEN592R030 
 splice_site_variant 
 c.990G>A 
 p.? 
 De novo 
  
 Simplex 
 GEN592R031 
 frameshift_variant 
 c.1662del 
 p.Thr555ProfsTer9 
 De novo 
  
 Simplex 
 GEN592R032 
 missense_variant 
 c.1705C>T 
 p.Leu569Phe 
 De novo 
  
 Simplex 
 GEN592R033 
 stop_gained 
 c.1726C>T 
 p.Arg576Ter 
 De novo 
  
 Simplex 
 GEN592R034 
 missense_variant 
 c.1733G>A 
 p.Arg578His 
 De novo 
  
 Simplex 
 GEN592R035 
 missense_variant 
 c.1841C>T 
 p.Ala614Val 
 De novo 
  
 Simplex 
 GEN592R036 
 stop_gained 
 c.1927G>T 
 p.Glu643Ter 
 De novo 
  
 Simplex 
 GEN592R037 
 frameshift_variant 
 c.1627del 
 p.Ser543GlnfsTer15 
 De novo 
  
  
 GEN592R038 
 copy_number_loss 
  
  
 Familial 
 Paternal 
 Simplex 
 GEN592R039 
 stop_gained 
 c.193G>T 
 p.Glu65Ter 
 Familial 
 Paternal 
 Simplex 
 GEN592R040 
 frameshift_variant 
 c.7dup 
 p.Ser3PhefsTer2 
 Familial 
 Paternal 
 Simplex 
 GEN592R041 
 splice_site_variant 
 c.1182T>G 
 p.Asp394Glu 
 De novo 
  
  
 GEN592R042 
 stop_gained 
 c.237G>A 
 p.Trp79Ter 
 Familial 
 Maternal 
 Multiplex (monozygotic twins) 
 GEN592R043 
 stop_gained 
 c.1726C>T 
 p.Arg576Ter 
 De novo 
  
 Simplex 
 GEN592R044 
 stop_gained 
 c.1153C>T 
 p.Arg385Ter 
 De novo 
  
  
 GEN592R045 
 missense_variant 
 c.1738C>T 
 p.Arg580Trp 
 De novo 
  
 Simplex 
 GEN592R046 
 stop_gained 
 c.1726C>T 
 p.Arg576Ter 
 De novo 
  
 Simplex 
 GEN592R047 
 missense_variant 
 c.482T>C 
 p.Leu161Pro 
 De novo 
  
 Simplex 
 GEN592R048 
 missense_variant 
 c.1730A>G 
 p.Glu577Gly 
 De novo 
  
 Simplex 
 GEN592R049 
 missense_variant 
 c.1805C>T 
 p.Thr602Ile 
 De novo 
  
 Simplex 
 GEN592R050 
 splice_site_variant 
 c.1146+1G>A 
  
 De novo 
  
 Simplex 
 GEN592R051 
 stop_gained 
 c.2032C>T 
 p.Arg678Ter 
 Unknown 
  
  
 GEN592R052 
 missense_variant 
 c.2045G>A 
 p.Arg682Gln 
 De novo 
  
  
 GEN592R053 
 missense_variant 
 c.2045G>A 
 p.Arg682Gln 
 De novo 
  
  
 GEN592R054 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 De novo 
  
 Simplex 
 GEN592R055 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 De novo 
  
 Simplex 
 GEN592R056 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 De novo 
  
 Simplex 
 GEN592R057 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 De novo 
  
 Simplex 
 GEN592R058 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 De novo 
  
 Simplex 
 GEN592R059 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 Unknown 
  
 Simplex 
 GEN592R060 
 missense_variant 
 c.2045G>A 
 p.Arg682Gln 
 De novo 
  
 Simplex 
 GEN592R061 
 missense_variant 
 c.187C>T 
 p.Pro63Ser 
 De novo 
  
 Simplex 
 GEN592R062 
 splice_site_variant 
 c.1572A>G 
 p.Gln524%3D 
 De novo 
  
  
 GEN592R063 
 missense_variant 
 c.2147C>T 
 p.Ala716Val 
 De novo 
  
  
 GEN592R064 
 missense_variant 
 c.1705C>T 
 p.Leu569Phe 
 De novo 
  
  
 GEN592R065 
 splice_site_variant 
 c.549+2T>G 
  
 De novo 
  
  
 GEN592R066 
 frameshift_variant 
 c.632_633insAT 
 p.Phe211LeufsTer24 
 Unknown 
  
  
 GEN592R067 
 splice_site_variant 
 c.369+1G>T 
  
 Unknown 
  
  
 GEN592R068 
 copy_number_loss 
  
  
 Unknown 
  
  
 GEN592R069 
 missense_variant 
 c.1849G>A 
 p.Val617Ile 
 Familial 
 Paternal 
 Multiplex 
 GEN592R070 
 splice_site_variant 
 c.2185+1G>A 
 p.? 
 De novo 
  
  
 GEN592R071 
 stop_gained 
 c.2182C>T 
 p.Arg728Ter 
 De novo 
  
 Simplex 
 GEN592R072 
 missense_variant 
 c.1165C>T 
 p.Arg389Cys 
 De novo 
  
  
  et al.  
 GEN592R073 
 stop_gained 
 c.469C>T 
 p.Arg157Ter 
 Unknown 
  
 Unknown 
  et al.  
 GEN592R074 
 missense_variant 
 c.655G>C 
 p.Asp219His 
 De novo 
  
  
  et al.  
 GEN592R075 
 missense_variant 
 c.2045G>A 
 p.Arg682Gln 
 Unknown 
  
 Multiplex 
  et al.  

Common

Variant ID
Polymorphism
SNP ID
Allele Change
Residue Change
Population Origin
Population Stage
Author, Year
 GEN592C001 
 intron_variant 
 rs9960767 
 c.146-23634T>G;c.452-23634T>G;c.74-23634T>G;c.140-23634T>G;c.19+22808T>G;c.560-23634T>G;c.416-23634T 
  
 SGENE-plus + follow-up + ISC + MGS (12,945 cases; 34,591 controls) 
 Discovery 
 GEN592C002 
 intron_variant 
 rs9960767 
 c.146-23634T>G;c.452-23634T>G;c.74-23634T>G;c.140-23634T>G;c.19+22808T>G;c.560-23634T>G;c.416-23634T 
  
 SGENE-plus + ISC + MGS and all follow-up (18 206 cases; 42 536 controls) 
 Replication 
 GEN592C003 
 intergenic_variant 
 rs5825114 
 G>GA 
  
 40,675 SCZ cases and 64,643 controls (CLOZUK and independent PGC datasets) 
 Discovery 
 GEN592C003 
 intron_variant 
 rs10503002 
 c.304+19048G>A;c.232+19048G>A;c.178+19048G>A;c.610+19048G>A 
  
 105,975 cases with self-reported irritability and 273,531 controls (all of European ancestry) from the UK Biobank 
 Discovery 
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
18
Duplication
 2
 
18
Duplication
 2
 
18
Duplication
 1
 
18
Duplication
 2
 
18
Deletion-Duplication
 14
 
18
Deletion
 2
 
18
Deletion
 2
 
18
Deletion
 5
 
18
Deletion-Duplication
 10
 

Model Summary

Tcf4 haploinsufficient mice have deficits in social interaction, ultrasonic vocalization, prepulse inhibition, and spatial and associative learning and memory and have Incresed general locomotor activity . Tcf4(+/) mice also show enhanced long-term potentiation in the CA1 area of the hippocampus. Hdac2 isoform-selective knockdown or adminstration of Hdac inhibitors can rescue memory deficits in Tcf4(+/) mice.

References

Type
Title
Author, Year
Primary
Tcf4 Regulates Synaptic Plasticity, DNA Methylation, and Memory Function.
Additional
Disruption of TCF4 regulatory networks leads to abnormal cortical development and mental disabilities.
Additional
Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression

M_TCF4_1_KO_HT

Model Type: Genetic
Model Genotype: Heterozygous
Mutation: The C-terminus DNA-binding domain of transcription factor 4 (Tcf4 or E2-2) was replaced with a neomycin cassette.
Allele Type: Targeted (Knock Out)
Strain of Origin: C57BL/6J and 129S1/SvImJ
Genetic Background: C57BL/6J*129S1/SvImJ
ES Cell Line: 129P2/OlaHsd
Mutant ES Cell Line: Not specified
Model Source: Jax Lab

M_TCF4_2_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Mice harboring a homozygous deletion of the C-terminus DNA-binding domain of transcription factor 4 (Tcf4 or E2-2) which was replaced with a neomycin cassette.
Allele Type: Targeted (Knock Out)
Strain of Origin: C57BL/6J and 129S1/SvImJ
Genetic Background: C57BL/6J*129S1/SvImJ
ES Cell Line: 129P2/OlaHsd
Mutant ES Cell Line: Not specified
Model Source: Jax Lab

M_TCF4_1_KO_HT

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Increased
Description: Increased general locomotor activity in tcf4 hets relative to wildtype controls
Exp Paradigm: Open field test: tcf4 hets show higher activity without affecting the overal time spent in the center of the field; elevated plus maze test: tcf4 hets show an increase in overall arm entrances without spending a significantly increased amount of time in the open arms- elevated plus maze test
 Elevated plus maze test
 2-3 months
Grip strength1
Decreased
Description: Tcf hets have weaker hindlimb, but not forelimb, grip strength relative to wildtype controls
Exp Paradigm: Grip strength test measures grip strength by using the grip strength meter
 Grip strength test
 2-3 months
General locomotor activity3
increased
Description: Tcf4tr/+ mice show more locomotor activity, significantly increased distance traveled
 Open field test
 P40-50
Paw preference1
Increased
Description: Tcf4 hets have asymmetry in the motor control and imbalance that favors their left side
Exp Paradigm: Dynamic weight bearing: tcf4 hets place more weight on their front left paw than their right; catwalk: tcf4 hets favor their front left paw while walking-dynamic weight bearing
 Dynamic weight bearing
 2-3 months
General locomotor activity1
Increased
Description: Increased general locomotor activity in tcf4 hets relative to wildtype controls
Exp Paradigm: Open field test: tcf4 hets show higher activity without affecting the overal time spent in the center of the field; elevated plus maze test: tcf4 hets show an increase in overall arm entrances without spending a significantly increased amount of time in the open arms-open field test
 Open field test
 2-3 months
Paw preference1
Increased
Description: Tcf4 hets have asymmetry in the motor control and imbalance that favors their left side
Exp Paradigm: Dynamic weight bearing: tcf4 hets place more weight on their front left paw than their right; catwalk: tcf4 hets favor their front left paw while walking- catwalk
 Footprint analysis
 2-3 months
Cell proliferation: neural precursors2
Abnormal
Description: Tcf4 het mice show an increase in the total number of late born neurons (e14) but a decrease in the total number of early born neurons (e12) at p4, p7 and p15, compared with controls, indicating a decrease in the generation of upper cortical layer neurons.
Exp Paradigm: Early and late born neurons were labelled with idu and cidu respectively at e12 and e14. cerebral cortex.
 Idu incorporation assay
 P4, p7, p15
Protein expression: in situ protein expression3
decreased
Description: Fewer phox2b immunoreactive neurons along the rostrocaudal extent of the retrotrapezoid nucleus (rtn) and parafacial lateral (pfl) regions from tcf4tr/+ mice compared to control tissue; 70% fewer phox2b labeled neurons in the pfl region; rtn also showed a 21% loss of phox2b-immunoreactivity
 In situ hybridization (ISH)
 P0, P12
Mortality/lethality: postnatal: incomplete penetrance3
increased
Description: Tcf4tr/+ also exhibit early high mortality (30%) but those reaching weaning age tended to survive at least two months
 Survival analysis
 
Anatomical projections and connectivity3
abnormal
Description: Cell type specific targeting of rtn projections to the pre-bötc was disrupted in tcf4tr/+ mice; phox2b parafacial neurons in phox2bcre::ai14::tcf4tr/+ animals project almost exclusively to sst-negative pre-bötc neurons, as opposed to sst-positive in control mice
 Immunohistochemistry
 Adult
Neuronal number3
decreased
Description: Average number of labeled pre-bötc neurons decreased from 144 cells per control mouse to 112 cells per tcf4tr/+ mouse
 Immunohistochemistry
 Adult
Dendritic architecture: dendritic tree complexity2
Decreased
Description: Tcf4 het mice show apical dendrites with scarce ramification and sparse basal dendrites compared with controls.
Exp Paradigm: Scattered in utero electroporation was performed using gfp at e14 and dendritic morphology of the posterior neocortex was examined at p15.
 Immunohistochemistry
 P15
Neuronal migration2
Decreased
Description: Tcf4 het mice show increased number of late born cldu labeled neurons remaining in the deep layers of the telencephalic wall en route to the cortical plate compared with controls, indicating a decrease in the migration of upper cortical layer neurons.
Exp Paradigm: Early and late born neurons were labelled with idu and cidu respectively at e12 and e14. cerebral cortex.
 Idu incorporation assay
 P4, p7, p15
Dendritic architecture: dendritic length2
Abnormal
Description: Tcf4 het mice show shorter basal dendrites and longer apical dendrites compared with controls.
Exp Paradigm: Scattered in utero electroporation was performed using gfp at e14 and dendritic morphology of the posterior neocortex was examined at p15.
 Immunohistochemistry
 P15
Protein expression: in situ protein expression3
decreased
Description: Glutamatergic phox2b+ parafacial neurons are selectively disrupted by loss of tcf4; the proportion of slc17a6+ and phox2b+ parafacial neurons decreased from 61 to 47%, while the proportion of slc17a6+ and phox2b-negative neurons remained similar in tissue from control and tcf4tr/+ mice, respectively
 In situ hybridization (ISH)
 P12
Neuronal migration2
Decreased
Description: Tcf4 het mice show accumulation of e14 injected gfp primarily in the deep cortical layers of cux1 negative neurons whereas wildtype controls show accumulation of e14 injected gfp primarily in the upper cortical layers of cux1 positive neurons, indicating reduced neuronal migration in mutants.
Exp Paradigm: Gfp was injected in utero into e14 embryos. cerebral cortex.
 Immunohistochemistry
 P15
Neuronal activation following behavioral stimulation: c-fos levels1
Increased
Description: Tcf4 hets have increased expression of fos (a transcription factor associated with memory formation in hippocampus) and tet2 (a 5-methyl cytosine hydroxylase) in the hippocampal ca1 tissue after training
Exp Paradigm: Rna sequencing: hippocampal ca1 collected after fear conditioning training
 Rna sequencing
 2-3 months
Neuronal activation3
decreased
Description: A blunted firing response to 10% co2
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: excitatory3
decreased
Description: Lower sepsc frequency under baseline conditions and in response to 10% co2
 Whole-cell patch clamp
 Adult
Synaptic plasticity: hippocampal ltp1
Increased
Description: Tcf4 hets have enhanced schaffer collateral ltp when activated with theta burst stimulation
Exp Paradigm: Field potential recordings: hippocampal sc-ca1 pathway (schaffer collateral axonal fibers - ca1): ltp induced by theta burst stimulation
 Field potential recordings
 2-3 months
Self grooming: perseveration1
Increased
Description: Tcf4 hets show increased self grooming relative to wildtype controls
Exp Paradigm: Grooming behavior assessments
 Grooming behavior assessments
 2-3 months
Startle response: acoustic stimulus1
Increased
Description: Tcf4 hets display increased acoustic startle reflex relative to wildtype controls
Exp Paradigm: Acoustic startle reflex test: 120db
 Acoustic startle reflex test
 2-3 months
Sensorimotor gating1
Decreased
Description: Decreased sensorimotor gating in tcf4 hets relative to wildtype controls
Exp Paradigm: Prepulse inhibition: a 4 khz prepulse is presented 0, 4, 8, and 16 db above a 65 db background white noise before the pulse (120 db)
 Prepulse inhibition
 2-3 months
Social approach1
Decreased
Description: Tcf4 hets prefer social isolation over interaction, unlike wildtype controls
Exp Paradigm: Three-chamber social approach test
 Three-chamber social approach test
 2-3 months
Respiratory function3
abnormal
Description: Tcf4tr/+ mice showed no abdominal emg response up to 7% co2
Exp Paradigm: graded increases in CO2; abdominal and diaphragm EMG
 Electromyogram (EMG)
 P50
Respiratory function3
abnormal
Description: Tcf4tr/+ mice show waxing and waning of minute ventilation resulting in unstable breathing evidenced by a large increase in minute ventilation coefficient of variation; ~75% of adult tcf4tr/+ mice exhibited a diminished occurrence of spontaneous sighs in conjunction with increased duration of post-sigh apnea; tcf4tr/+ mice show a diminished capacity to increase minute ventilation in response to 5 and 7% co2; normal ventilatory response to hypoxia
Exp Paradigm: room air; graded increases in CO2
 Whole body plethysmography
 P45
Ultrasonic vocalization: isolation induced1
Decreased
Description: Tcf4 het pups (p3-p5) have reduced usv occurrence and weaker calls (p3) when they are removed from the nest
Exp Paradigm: The strength of calls is measured at the maximum pressure (in decibels) between 20 and 100 khz during the 5 min test window
 Monitoring ultrasonic vocalizations
 P3-p5
Ultrasonic vocalization: alarm1
Decreased
Description: Tcf4 het pups (p3) have reduced usv occurrence and weaker calls when they are under stress
Exp Paradigm: Ultrasonic distress calls are elicited by lifting and holding the pup by hand for 30 sec after the 5 min usv detection period
 Monitoring ultrasonic vocalizations
 P3
Size/growth3
decreased
Description: Tcf4tr/+ mice show decreased body weight
 Body weight measurment
 P3, P20
Anxiety3
decreased
Description: Tcf4tr/+ mice show higher frequency of entering the center region
 Open field test
 P40-50
Spatial reference memory1
Decreased
Description: Tcf4 hets display decreased spatial memory examined by morris water maze test and object-place recognition test
Exp Paradigm: Morris water maze test: time in target quadrant or platform crossings; object-place recognition test-morris water maze test
 Morris water maze test
 2-3 months
Cued or contextual fear conditioning: trace fear conditioning1
Decreased
Description: Decreased memory of cue in trace fear conditioning test relative to wildtype controls
Exp Paradigm: Fear conditioning test: cued memory is assessed 1 day or 11 days after training
 Fear conditioning test
 2-3 months
Spatial reference memory1
Decreased
Description: Tcf4 hets display decreased spatial memory examined by morris water maze test and object-place recognition test
Exp Paradigm: Morris water maze test: time in target quadrant or platform crossings; object-place recognition test- object-place recognition test
 Object-place recognition test
 2-3 months
Cued or contextual fear conditioning: memory of cue1
Decreased
Description: Decreased memory of cue in fear conditioning test with normal learning ability relative to wildtype controls
Exp Paradigm: Fear conditioning test: a training protocol is used to pair three white noise tones (cs) with a foot shock (us) presented 15 sec after the end of the cs; the memory is tested 24 hr after training sessions
 Fear conditioning test
 2-3 months
Spatial learning1
Decreased
Description: Tcf4 hets display impaired spatial learning with normal willingness and swim ability
Exp Paradigm: Morris water maze test: latency to platform; object-place recognition test-morris water maze test
 Morris water maze test
 2-3 months
Cued or contextual fear conditioning: memory of context1
Decreased
Description: Decreased memory of context in fear conditioning test with normal learning ability relative to wildtype controls
Exp Paradigm: Fear conditioning test: a training protocol is used to pair three white noise tones (cs) with a foot shock (us) presented 15 sec after the end of the cs; the memory is tested 24 hr after training sessions
 Fear conditioning test
 2-3 months
Spatial learning1
Decreased
Description: Tcf4 hets display impaired spatial learning with normal willingness and swim ability
Exp Paradigm: Morris water maze test: latency to platform; object-place recognition test- object-place recognition test
 Object-place recognition test
 2-3 months
Gene expression1
Decreased
Description: Tcf4 hets have decreased expression of learning/memory-associated genes (nmdar, grin2a, npy2r, lpar1, arc, and s1pr5), myelination associated genes (aspa, epb4.1l3, fa2h, gfap, gjb1, gjc2, kcnj10, litaf, mag, mal, mobp, nefm,and ugt8a), and lefty1 in the hippocampal ca1 tissue
Exp Paradigm: Rna sequencing: hippocampal ca1
 Rna sequencing
 2-3 months
Targeted expression3
decreased
Description: Parafacial astrocytes in tcf4tr/+ mice crossed with an astrocyte specific inducible reporter (gfapcre/ert2) did not express tcf4 transcript
 Quantitative PCR (qRT-PCR)
 P12
Gene expression2
Abnormal
Description: Tcf4 het mice show upregulated genes primarily in the ventricular and sub ventricular zone enriched in genes involved in the proliferation of neurons, cell fate determination and cell migration and downregulated genes in the cortical plate and intermediate zone enriched in genes involved in schizophrenia, neurotransmitter release and sodium transporter activity, compared with controls, indicating a neocortical shift toward immature neurons (geo#: gse79663)
Exp Paradigm: Dorsal telencephalon
 Rna sequencing
 P0
Protein expression level evidence3
increased
Description: Detectable levels of scn10a transcript in phox2b+ neurons from adult tcf4tr/+ mice but not age matched tcf4+/+ control animals
Exp Paradigm: FACS to obtain an enriched populations of TdT-positive cells from each genotype for subsequent targeted qPCR analysis of Scn10a transcript
 Quantitative PCR (qRT-PCR)
 Adult
Dna methylation1
Decreased
Description: Tcf4 hets display reduced methylation across all gene bodies that is enriched with the upregulated differentially expressed genes; no change in the global methylation patterns across promoter regions
Exp Paradigm: Cpg methylomics analysis
 Cpg methylomics analysis
 2-3 months
Gene expression1
Increased
Description: Tcf4 hets have increased expression of neuroreceptor genes (drd1a, cckbr, chrm4, oxtr, htr2c, glra2, glra3, and nmbr) and klotho (kl) in the hippocampal ca1 tissue
Exp Paradigm: Rna sequencing: hippocampal ca1
 Rna sequencing
 2-3 months
Ultrasonic vocalization: alarm1
 No change
 Monitoring ultrasonic vocalizations
 P5-p11
Ultrasonic vocalization: isolation induced1
 No change
 Monitoring ultrasonic vocalizations
 P7-p11
Mortality/lethality: embryonic3
 no change
 General observations
 P0
Size/growth3
 no change
 Body weight measurment
 P44
Anxiety1
 No change
 Elevated plus maze test
 2-3 months
Anxiety1
 No change
 Open field test
 2-3 months
Gene expression1
 No change
 Rna sequencing
 2-3 months
Motor coordination and balance1
 No change
 Accelerating rotarod test
 2-3 months
Motor coordination and balance1
 No change
 Horizontal ladder test
 2-3 months
Astrocyte morphology3
 no change
 Histology
 P12
Cortical lamination2
 No change
 Immunohistochemistry
 P0
Protein expression: in situ protein expression3
 no change
 In situ hybridization (ISH)
 P12
Action potential property: firing rate3
 no change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: excitatory3
 no change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current amplitude: inhibitory3
 no change
 Whole-cell patch clamp
 Adult
Miniature post synaptic current frequency: inhibitory3
 no change
 Whole-cell patch clamp
 Adult
Metabolic function3
 no change
 Whole body plethysmography
 P45
Seizures3
 no change
 Electroencephalogram (EEG)
 P60-64
Vision1
 No change
 Morris water maze test
 2-3 months
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior

M_TCF4_2_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Cortical lamination1
Decreased
Description: Tcf4 null mice show almost no cux1 (layers 2,3,4 in the sensory cortices) positive neurons in the upper cortical layers in the visual and parietal cortices but retain some cux1 expression in the frontal and motor cortices; increase in superficial layer markers satb2 and brn2 in deeper cortical layers particularly in the occipital and frontal cortices , indicating a defect in migration resulting in aberrant cortical lamination; no change in layer 5 marker ctip2; and reduction in layer 6 marker tbr1 compared with controls. tcf4 null mice do not show a gradient effect of the reduction in tbr1-positive cells along the anteriorposterior axis of the neocortex.
Exp Paradigm: Posterior neocortex
 Immunohistochemistry
 P0
Cell proliferation: neural precursors1
Increased
Description: Tcf4 null mice show increased proliferation of early and mid neurogenesis stage neuronal precursors compared with controls.
Exp Paradigm: Cerebral cortex
 Idu incorporation assay
 E12-e14
Cell proliferation: neural precursors1
Increased
Description: Tcf4 null mice show increase in ki67 and phospho-histone h3 positive neurons in the cerebral cortex at e12 and e14 compared with controls, indicating an increase in cell proliferation. tcf4 null mice show increase in tbr2 positive intermediate progenitor neurons in the ventricular and subventricular zones of the cerebral cortex compared with controls.
Exp Paradigm: Ventricular and subventricular zones of the cerebral cortex
 Immunohistochemistry
 E12, e14
Protein expression: in situ protein expression2
decreased
Description: Phox2b labeling is significantly diminished in rtn and pfl parafacial regions
 In situ hybridization (ISH)
 P0
Size/growth2
decreased
Description: Tcf4tr/tr mice show decreased body weight
 Body weight measurment
 P3
Mortality/lethality: neonatal2
increased
Description: 100% mortality by 4 days of age
 Survival analysis
 
Mortality/lethality: embryonic: incomplete penetrance2
increased
Description: ~30% tcf4tr/tr mice were stillborn
 General observations
 P0
Gene expression1
Abnormal
Description: Tcf4 het mice show upregulated genes primarily in the ventricular and sub ventricular zone enriched in genes involved in the proliferation of neurons, cell fate determination and cell migration and downregulated genes in the cortical plate and intermediate zone enriched in genes involved in schizophrenia, neurotransmitter release and sodium transporter activity, compared with controls, indicating a neocortical shift toward immature neurons (geo#: gse79663)
Exp Paradigm: Dorsal telencephalon
 Rna sequencing
 P0
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Sensory, Social behavior


Interactor Symbol Interactor Name Interactor Organism Entrez ID Uniprot ID Interaction Type Evidence Reference
AES amino-terminal enhancer of split 166 Q08117 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
AQP1 aquaporin 1 (Colton blood group) 358 P29972 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ARFGAP2 ADP-ribosylation factor GTPase activating protein 2 84364 B4DX29 IP; LC-MS/MS
Huttlin EL , et al. 2015
ARHGEF1 Rho guanine nucleotide exchange factor (GEF) 1 9138 Q92888 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ARMC7 armadillo repeat containing 7 79637 Q9H6L4 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ASCL4 achaete-scute family bHLH transcription factor 4 121549 Q6XD76 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ASPSCR1 alveolar soft part sarcoma chromosome region, candidate 1 79058 Q9BZE9 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
BCAS2 breast carcinoma amplified sequence 2 10286 B2R7W3 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
BCL2L2 BCL2-like 2 599 Q92843 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
BZRAP1 benzodiazapine receptor (peripheral) associated protein 1 9256 O95153 Y2H
Corominas R , et al. 2014
C19ORF66 chromosome 19 open reading frame 66 55337 Q9NUL5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
C1ORF109 chromosome 1 open reading frame 109 54955 Q9NX04 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
C9ORF171 chromosome 9 open reading frame 171 389799 Q6ZQR2 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CABP5 calcium binding protein 5 56344 Q9NP86 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CBFA2T3 core-binding factor, runt domain, alpha subunit 2; translocated to, 3 863 O75081 IP; LC-MS/MS
Huttlin EL , et al. 2015
CCDC101 coiled-coil domain containing 101 112869 Q96ES7 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CCDC101 coiled-coil domain containing 101 112869 Q96ES7 IP; LC-MS/MS
Huttlin EL , et al. 2015
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 1026 P38936 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CDKN2C cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) 1031 P42773 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CHAF1A chromatin assembly factor 1, subunit A (p150) 10036 Q13111 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CHCHD2 KIT 51142 Q9Y6H1 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CHD8 chromodomain helicase DNA binding protein 8 57680 Q9HCK8 CHIP-seq
Cotney J , et al. 2015
CHIC2 cysteine-rich hydrophobic domain 2 26511 Q9UKJ5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CKS1B CDC28 protein kinase regulatory subunit 1B 1163 P61024 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
CTBP1 C-terminal binding protein 1 1487 Q13363 Y2H
Corominas R , et al. 2014
CTNNB1 catenin (cadherin-associated protein), beta 1, 88kDa 1499 Q9WU82 X-ray crystallography
Graham TA , et al. 2001
DDX6 DEAD (Asp-Glu-Ala-Asp) box helicase 6 1656 P26196 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
DEF6 differentially expressed in FDCP 6 homolog (mouse) 50619 Q9H4E7 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
DGCR6 DiGeorge syndrome critical region gene 6 8214 Q14129 Y2H
Corominas R , et al. 2014
DMRT3 doublesex and mab-3 related transcription factor 3 58524 Q9NQL9 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EFHC1 EF-hand domain (C-terminal) containing 1 114327 B2CKC5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EIF4E2 eukaryotic translation initiation factor 4E family member 2 9470 O60573 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 1978 Q13541 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EPB41L3 erythrocyte membrane protein band 4.1-like 3 23136 Q9Y2J2 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EPHB6 EPH receptor B6 2051 J3KQU5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
EXOSC1 exosome component 1 51013 Q9Y3B2 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FAH fumarylacetoacetate hydrolase (fumarylacetoacetase) 2184 P16930 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FAM124B Protein FAM124B 79843 Q9H5Z6 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FAM74A4 family with sequence similarity 74, member A4 401508 Q5TZK3 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FERD3L Fer3-like bHLH transcription factor 222894 Q96RJ6 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FERD3L Fer3-like bHLH transcription factor 222894 Q96RJ6 IP; LC-MS/MS
Huttlin EL , et al. 2015
FLAD1 FAD1 flavin adenine dinucleotide synthetase homolog (S. cerevisiae) 80308 Q8NFF5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FLJ32679 440321 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FLNA filamin A, alpha 2316 P21333 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
FRS3 fibroblast growth factor receptor substrate 3 10817 O43559 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
GEM GTP binding protein overexpressed in skeletal muscle 2669 A0A024R9F5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
GLRX3 glutaredoxin 3 10539 O76003 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
GNG10 guanine nucleotide binding protein (G protein), gamma 10 2790 A0A024R156 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
GOLGA8EP golgin A8 family, member E, pseudogene 390535 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
GORASP2 golgi reassembly stacking protein 2, 55kDa 26003 Q9H8Y8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
GUCD1 Protein GUCD1 83606 Q96NT3 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
HAND2 heart and neural crest derivatives expressed 2 9464 P61296 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
HAT1 histone acetyltransferase 1 8520 O14929 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
HEXIM2 hexamethylene bis-acetamide inducible 2 124790 Q96MH2 IP; LC-MS/MS
Huttlin EL , et al. 2015
HMG20A high mobility group 20A 10363 Q9NP66 IP; LC-MS/MS
Huttlin EL , et al. 2015
ID1 inhibitor of DNA binding 1, dominant negative helix-loop-helix protein 3397 P41134 IP; LC-MS/MS
Huttlin EL , et al. 2015
ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 3398 Q02363 IP; LC-MS/MS
Huttlin EL , et al. 2015
ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 3399 Q02535 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ID3 inhibitor of DNA binding 3, dominant negative helix-loop-helix protein 3399 Q02535 IP; LC-MS/MS
Huttlin EL , et al. 2015
ID4 inhibitor of DNA binding 4, dominant negative helix-loop-helix protein 3400 P47928 IP; LC-MS/MS
Huttlin EL , et al. 2015
INS insulin 3630 I3WAC9 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
KCTD14 potassium channel tetramerization domain containing 14 65987 Q9BQ13 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
KIAA0182 Gse1 coiled-coil protein 23199 Q14687 IP; LC-MS/MS
Huttlin EL , et al. 2015
KLC3 kinesin light chain 3 147700 Q6P597 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
KLHL32 kelch-like family member 32 114792 Q96NJ5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LASP1 LIM and SH3 protein 1 NM_006148 B4DIC4 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LENG1 leukocyte receptor cluster (LRC) member 1 NM_024316 Q96BZ8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LGALS14 lectin, galactoside-binding, soluble, 14 56891 Q8TCE9 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LMO1 LIM domain only 1 (rhombotin 1) 4004 P25800 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LMO4 LIM domain only 4 8543 P61968 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
LNPEP leucyl/cystinyl aminopeptidase 4012 Q9UIQ6 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MAD2L2 MAD2 mitotic arrest deficient-like 2 (yeast) 10459 Q9UI95 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MAGOHB mago-nashi homolog B (Drosophila) 55110 Q96A72 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MAPKBP1 mitogen-activated protein kinase binding protein 1 NM_001128608 O60336 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MATN3 matrilin 3 4148 O15232 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MEMO1 mediator of cell motility 1 51072 Q9Y316 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MESP2 Mesoderm posterior protein 2 145873 Q0VG99 IP; LC-MS/MS
Huttlin EL , et al. 2015
MLLT6 myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 4302 P55198 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MORN4 MORN repeat containing 4 118812 A6XB87 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MRFAP1L1 Morf4 family associated protein 1-like 1 114932 Q96HT8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MRPL10 mitochondrial ribosomal protein L10 124995 Q7Z7H8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MSRB3 methionine sulfoxide reductase B3 253827 Q8IXL7 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MVP major vault protein 9961 Q14764 Y2H
Corominas R , et al. 2014
MYF6 myogenic factor 6 (herculin) 4618 P23409 IP; LC-MS/MS
Huttlin EL , et al. 2015
MYO5B myosin VB 4645 Q9ULV0 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
MYOG myogenin (myogenic factor 4) 4656 P15173 IP; LC-MS/MS
Huttlin EL , et al. 2015
NCK2 NCK adaptor protein 2 8440 O43639 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NDOR1 NADPH dependent diflavin oxidoreductase 1 27158 Q9UHB4 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NEK6 NIMA-related kinase 6 10783 Q9HC98 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NEK8 NIMA-related kinase 8 284086 Q86SG6 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NEU4 sialidase 4 129807 B3KR54 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NEUROD1 Neurogenic differentiation factor 1 4760 Q13562 IP; LC-MS/MS
Huttlin EL , et al. 2015
NEUROG1 neurogenin 1 4762 F1T0H3 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NEUROG3 Neurogenin-3 50674 Q9Y4Z2 IP; LC-MS/MS
Huttlin EL , et al. 2015
NME7 NME/NM23 family member 7 29922 Q9Y5B8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NMUR2 neuromedin U receptor 2 56923 Q9GZQ4 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NOL9 nucleolar protein 9 79707 Q5SY16 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NR2C2AP nuclear receptor 2C2-associated protein 126382 Q86WQ0 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
NUDT10 nudix (nucleoside diphosphate linked moiety X)-type motif 10 170685 Q8NFP7 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ORC4 origin recognition complex, subunit 4 5000 O43929 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
OSGIN1 oxidative stress induced growth inhibitor 1 29948 Q9UJX0 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
OTUD4 OTU domain containing 4 54726 Q01804 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PARK2 parkinson protein 2, E3 ubiquitin protein ligase (parkin) 5071 O60260 Y2H
Corominas R , et al. 2014
PATE1 prostate and testis expressed 1 160065 Q8WXA2 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PBLD Phenazine biosynthesis-like domain-containing protein 64081 P30039 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PIN1 peptidylprolyl cis/trans isomerase, NIMA-interacting 1 5300 Q13526 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PLEKHN1 pleckstrin homology domain containing, family N member 1 84069 Q494U1 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
POLR1A polymerase (RNA) I polypeptide A, 194kDa 25885 O95602 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
POLR1C polymerase (RNA) I polypeptide C, 30kDa 9533 O15160 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PPIA peptidylprolyl isomerase A (cyclophilin A) 5478 P62937 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PPIL1 peptidylprolyl isomerase (cyclophilin)-like 1 51645 Q9Y3C6 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PPP1R18 protein phosphatase 1, regulatory subunit 18 170954 Q6NYC8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PRKAA2 protein kinase, AMP-activated, alpha 2 catalytic subunit 5563 P54646 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PRKAB2 protein kinase, AMP-activated, beta 2 non-catalytic subunit 5565 O43741 Y2H
Corominas R , et al. 2014
PSMA1 proteasome (prosome, macropain) subunit, alpha type, 1 5682 P25786 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PSMG2 proteasome (prosome, macropain) assembly chaperone 2 56984 Q969U7 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
PTGER3 prostaglandin E receptor 3 (subtype EP3) 5733 P43115 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
RAB41 RAB41, member RAS oncogene family 347517 Q5JT25 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
RABIF RAB interacting factor 5877 P47224 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
RECK reversion-inducing-cysteine-rich protein with kazal motifs 8434 A8K9D8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
RELA v-rel reticuloendotheliosis viral oncogene homolog A (avian) 5970 Q04206 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
REXO1L6P REX1, RNA exonuclease 1 homolog (S. cerevisiae)-like 6, pseudogene 441362 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
RSPH14 rhabdoid tumor deletion region gene 1 27156 Q9UHP6 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
RUNX1T1 runt-related transcription factor 1; translocated to, 1 (cyclin D-related) 862 B2R6I9 IP; LC-MS/MS
Huttlin EL , et al. 2015
SCOC short coiled-coil protein 60592 Q9UIL1 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SEC14L4 SEC14-like 4 (S. cerevisiae) 284904 B2RMR2 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SIGLEC6 sialic acid binding Ig-like lectin 6 946 O43699 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SLC39A13 solute carrier family 39 (zinc transporter), member 13 91252 Q96H72 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SLC4A1AP solute carrier family 4 (anion exchanger), member 1, adaptor protein 22950 Q9BWU0 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SMCP sperm mitochondria-associated cysteine-rich protein 4184 P49901 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SMOC1 SPARC related modular calcium binding 1 64093 Q9H4F8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SPATC1L spermatogenesis and centriole associated 1-like 84221 Q9H0A9 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SPG21 spastic paraplegia 21 (autosomal recessive, Mast syndrome) 51324 Q9NZD8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SRSF2 serine/arginine-rich splicing factor 2 6427 Q01130 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
STAMBPL1 STAM binding protein-like 1 57559 Q96FJ0 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
STK16 serine/threonine kinase 16 8576 O75716 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
STX11 syntaxin 11 8676 O75558 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
SZT2 seizure threshold 2 homolog (mouse) 23334 Q5T011 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TAL2 T-cell acute lymphocytic leukemia 2 6887 Q16559 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TAPBPL TAP binding protein-like 55080 Q9BX59 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TCEA2 transcription elongation factor A (SII), 2 6919 Q15560 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TCF12 transcription factor 12 6938 Q99081 IP; LC-MS/MS
Huttlin EL , et al. 2015
TCF24 Transcription factor 24 100129654 Q7RTU0 IP; LC-MS/MS
Huttlin EL , et al. 2015
TCF3 transcription factor 3 6929 P15923 IP; LC-MS/MS
Huttlin EL , et al. 2015
TMEM213 transmembrane protein 213 155006 A2RRL7 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TRAPPC2L trafficking protein particle complex 2-like 51693 Q9UL33 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TSSC4 tumor suppressing subtransferable candidate 4 10078 Q9Y5U2 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TSSK3 testis-specific serine kinase 3 81629 Q96PN8 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TWIST1 twist homolog 1 (Drosophila) 7291 Q15672 IP; LC-MS/MS
Huttlin EL , et al. 2015
TWIST2 twist family bHLH transcription factor 2 117581 A0A024R4D4 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
TWIST2 twist family bHLH transcription factor 2 117581 A0A024R4D4 IP; LC-MS/MS
Huttlin EL , et al. 2015
TXNL4B thioredoxin-like 4B NM_001142318 Q9NX01 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
UTP23 UTP23, small subunit (SSU) processome component, homolog (yeast) 84294 Q9BRU9 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
VPS28 vacuolar protein sorting 28 homolog (S. cerevisiae) 51160 Q548N1 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ZDHHC24 zinc finger, DHHC-type containing 24 254359 Q6UX98 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ZNF124 zinc finger protein 124 7678 Q15973 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ZNF205-AS1 ZNF205 antisense RNA 1 81854 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ZNF417 zinc finger protein 417 147687 Q8TAU3 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
ZNF587 zinc finger protein 587 84914 G3V0H5 Y2H; bimolecular fluorescence complementation assay
Rolland T , et al. 2014
Nrxn1 neurexin 1 18189 Q9CS84 ChIP-qPCR
D'Rozario M , et al. 2016
Kcnq1 potassium voltage-gated channel subfamily Q member 1 84020 Q9Z0N7 ChIP-Seq; TRAP
Rannals MD , et al. 2016
Kcnq4 potassium voltage-gated channel subfamily Q member 4 298496 Q9JK96 ChIP-Seq
Rannals MD , et al. 2016
Scn10a sodium voltage-gated channel alpha subunit 10 29571 Q62968 ChIP-Seq; TRAP
Rannals MD , et al. 2016

HELP
Copyright © 2017 MindSpec, Inc.